Effect of Perioperative Pirfenidone Treatment in Lung Cancer Patients With Idiopathic Pulmonary Fibrosis Takekazu Iwata, MD, PhD, Shigetoshi Yoshida,

Slides:

Advertisements

Similar presentations

Survival Benefit of Aortic Valve Replacement in Patients With Severe Aortic Stenosis With Low Ejection Fraction And Low Gradient With Normal Ejection.

Advertisements

Pulmonary Resection for Lung Cancer in Patients With Idiopathic Interstitial Pneumonia Takahiro Omori, MD, Michihiko Tajiri, MD, PhD, Tomohisa Baba, MD,

Treating Constrictive Pericarditis in a Chinese Single-Center Study: A Five-Year Experience Yiyun Lin, MD, Mi Zhou, MMS, Jian Xiao, MD, Bin Wang, MD,

Mauer Biscotti, MD, Whitney D

Survival After Surgical Resection for Lung Cancer in Patients With Chronic Obstructive Pulmonary Disease Anders Bugge, MD, May Brit Lund, MD, PhD, Cathrine.

Complete Thoracic Mediastinal Lymphadenectomy Leads to a Higher Rate of Pathologically Proven N2 Disease in Patients With Non-Small Cell Lung Cancer

Number of Lymph Nodes and Metastatic Lymph Node Ratio Are Associated With Survival in Lung Cancer Chukwumere E. Nwogu, MD, Adrienne Groman, MA, Daniel.

Melanie Subramanian, MD, Timothy McMurry, PhD, Bryan F

Outcomes of Reintervention on the Autograft After Ross Procedure

Association of Perioperative Fluid Balance and Adverse Surgical Outcomes in Esophageal Cancer and Esophagogastric Junction Cancer Shenhai Wei, MD, PhD,

Joshua E. Rosen, BASc, Hari B

Long Interspersed Nucleotide Element 1 Hypomethylation Is Associated With Poor Prognosis of Lung Adenocarcinoma Koei Ikeda, MD, PhD, Kenji Shiraishi,

Amiodarone Significantly Decreases Atrial Fibrillation in Patients Undergoing Surgery for Lung Cancer Lars P. Riber, MD, PhD, Thomas D. Christensen,

Lisa M. Brown, MD, MAS, David T. Cooke, MD, Elizabeth A. David, MD

Long-Term Consequences of Postoperative Heart Failure After Surgery for Aortic Stenosis Compared With Coronary Surgery Farkas B. Vánky, MD, PhD, Erik.

Osteopontin Combined With CD44v6, a Novel Prognostic Biomarker in Non-Small Cell Lung Cancer Undergoing Curative Resection Bing-sheng Sun, MD, PhD, Yue.

Influence of Pulmonary Hypertension on Patients With Idiopathic Pulmonary Fibrosis Awaiting Lung Transplantation Don Hayes, MD, MS, Sylvester M. Black,

Lymph Node Evaluation Achieved by Open Lobectomy Compared With Thoracoscopic Lobectomy for N0 Lung Cancer Robert E. Merritt, MD, Chuong D. Hoang, MD,

Operative Results and Outcomes in Children With Shone's Anomaly

Hanan A. Tanash, PhD, Gerdt C. Riise, PhD, Magnus P

Prognostic Predictors in Non-Small Cell Lung Cancer Patients Undergoing Intentional Segmentectomy Terumoto Koike, MD, PhD, Teruaki Koike, MD, PhD, Yasushi.

Michelle C. Ellis, MD, Brian S. Diggs, PhD, John T. Vetto, MD, Paul H

Philip W. Smith, MD, Hongkun Wang, PhD, Leo M. Gazoni, MD, K

Chris Dickhoff, MD, Max Dahele, MD, PhD, Sayed M

Pulmonary Resection in the Treatment of Multidrug-Resistant Tuberculosis: A Retrospective Study of 56 Cases Haifeng Wang, MM, Hongsheng Lin, MM, Gening.

Surgical Outcomes of Patients With Stage III Thymoma in the Japanese Nationwide Database Yoshito Yamada, MD, PhD, Ichiro Yoshino, MD, PhD, Jun Nakajima,

Positron Emission Tomography-Computed Tomography for Postoperative Surveillance in Non-Small Cell Lung Cancer Se Hoon Choi, MD, Young Tae Kim, MD, PhD,

Community-Based Multidisciplinary Computed Tomography Screening Program Improves Lung Cancer Survival Daniel L. Miller, MD, William R. Mayfield, MD,

Lung Cancer Surgery in Patients With Liver Cirrhosis

Total Arterial Revascularization: A Superior Strategy for Diabetic Patients Who Require Coronary Surgery James Tatoulis, MD, FRACS, Rochelle Wynne, PhD,

Asad A. Shah, MD, Mathias Worni, MD, MHS, Christopher R

Impact of Lepidic Component Occupancy on Effects of Adjuvant Chemotherapy for Lung Adenocarcinoma Shinsuke Sasada, MD, PhD, Yoshihiro Miyata, MD, PhD,

Video-Assisted Thoracic Surgery Thymectomy Versus Sternotomy Thymectomy in Patients With Thymoma Hiroyuki Agatsuma, MD, Kazuo Yoshida, MD, PhD, Ichiro.

Age-Dependent Gender Disparities in Post Lung Transplant Survival Among Patients With Idiopathic Pulmonary Fibrosis Shahid I. Sheikh, MD, Don Hayes,

Use of Amiodarone After Major Lung Resection

Elliot Wakeam, MD, MPH, James P. Byrne, MD, Gail E

Impact of Blood Product Transfusion on Short and Long-Term Survival After Cardiac Surgery: More Evidence Balu Bhaskar, MD, FCICM, Joel Dulhunty, PhD,

Survival After Surgery for Pathologic Stage IA Non-Small Cell Lung Cancer Associated With Idiopathic Pulmonary Fibrosis Yuichi Saito, MD, Yasuyuki Kawai,

Recurrence and Survival After Segmentectomy in Patients With Prior Lung Resection for Early-Stage Non-Small Cell Lung Cancer Lisa M. Brown, MD, Brian.

Matthew J. Bott, MD, Hanghang Wang, BA, William Travis, MD, Gregory J

Risk Factors for Developing Postthymectomy Myasthenia Gravis in Thymoma Patients Yoshito Yamada, MD, PhD, Shigetoshi Yoshida, MD, PhD, Takekazu Iwata,

Kathryn E. Engelhardt, MD, Malcolm M. DeCamp, MD, Anthony D

Patient Preferences in Treatment Choices for Early-Stage Lung Cancer

Surgical Repair for Acute Type A Aortic Dissection in Octogenarians

Eric S. Weiss, MD, MPH, Jeremiah G. Allen, MD, Christian A

Radiofrequency Ablation for the Treatment of Pulmonary Metastases

Pulmonary Resection for Lung Cancer in Octogenarians

Postoperative Extracorporeal Membrane Oxygenation Support for Acute Type A Aortic Dissection Ting-Wei Lin, MD, MS, Meng-Ta Tsai, MD, Yu-Ning Hu, MD,

Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration for Differentiating N0 Versus N1 Lung Cancer Kazuhiro Yasufuku, MD, PhD, Takahiro Nakajima,

Pattern of Metastasis Outside Tumor-Bearing Segments in Primary Lung Cancer: Rationale for Segmentectomy Yuichi Sakairi, MD, PhD, Ichiro Yoshino, MD,

The Feasibility of Median Sternotomy With or Without Thoracotomy for Locally Advanced Non-Small Cell Lung Cancer Treated With Induction Chemoradiotherapy

Completely Thrombosed Tricuspid Pouch Mimicking a Cardiac Tumor

A. Thomas Pezzella, MD, Sari D

The Annals of Thoracic Surgery

Prognostic Significance of Aberrant Methylation of Solute Carrier Gene Family 5A8 in Lung Adenocarcinoma Koei Ikeda, MD, PhD, Kenji Shiraishi, MD, PhD,

Adhering to Quality Measures in Esophagectomy Is Associated With Improved Survival in All Stages of Esophageal Cancer Pamela Samson, MD, MPHS, Varun.

Lymph Node Staging by Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration in Patients With Small Cell Lung Cancer Hironobu Wada, MD, Takahiro.

Nabin K. Shrestha, MD, MPH, Jennifer Jue, MD, Syed T

Prognostic Heterogeneity in Multilevel N2 Non-Small Cell Lung Cancer Patients: Importance of Lymphadenopathy and Occult Intrapulmonary Metastases Yukinori.

Endovascular Treatment of Type B Aortic Dissection: The Challenge of Late Success Claudia Maria Rodrigues Alves, MD, PhD, José Honório Palma da Fonseca,

Neal S Goldstein, MD The Annals of Thoracic Surgery

Effect of Formalin Fixation on Tumor Size Determination in Stage I Non-Small Cell Lung Cancer Po-Kuei Hsu, MD, Hsu-Chih Huang, MD, Chih-Cheng Hsieh,

Clinical Outcome After Pulmonary Resection for Lung Cancer Patients on Hemodialysis Toshiro Obuchi, MD, Wakako Hamanaka, MD, Yasuhiro Yoshida, MD, Jun.

Increased Rehospitalization Rate After Coronary Bypass Operation for Acute Coronary Syndrome: A Prospective Study in 200 Patients Staffan Bjessmo, MD,

Survival and Outcomes of Pulmonary Resection for Non-Small Cell Lung Cancer in the Elderly: A Nested Case-Control Study Robert J. Cerfolio, MD, Ayesha.

Lobectomy Versus Limited Resection in T1N0 Lung Cancer

Domenico Galetta, MD, PhD, Lorenzo Spaggiari, MD, PhD

Early Surgical Results After Pneumonectomy for Non-Small Cell Lung Cancer are not Affected by Preoperative Radiotherapy and Chemotherapy Tomas Gudbjartsson,

Surgical Outcomes of Acute Type A Aortic Dissection in Elderly Patients Kazunori Komatsu, MD, Tamaki Takano, MD, PhD, Takamitsu Terasaki, MD, Yuko Wada,

Magnus Dalén, MD, Torbjörn Ivert, MD, PhD, Martin J

Presentation transcript:

Effect of Perioperative Pirfenidone Treatment in Lung Cancer Patients With Idiopathic Pulmonary Fibrosis Takekazu Iwata, MD, PhD, Shigetoshi Yoshida, MD, PhD, Taiki Fujiwara, MD, PhD, Hironobu Wada, MD, PhD, Takahiro Nakajima, MD, PhD, Hidemi Suzuki, MD, PhD, Ichiro Yoshino, MD, PhD The Annals of Thoracic Surgery Volume 102, Issue 6, Pages 1905-1910 (December 2016) DOI: 10.1016/j.athoracsur.2016.05.094 Copyright © 2016 The Society of Thoracic Surgeons Terms and Conditions

Fig 1 (A) Kaplan-Meier progression-free survival for idiopathic pulmonary fibrosis (IPF), comparing the perioperative pirfenidone treatment (PPT) group with the non-PPT group. The first acute exacerbation (AE) after operation was treated as a progression event. (B) Cumulative incidence curves depicting first AE-IPF after operation for PPT and non-PPT patients. The Annals of Thoracic Surgery 2016 102, 1905-1910DOI: (10.1016/j.athoracsur.2016.05.094) Copyright © 2016 The Society of Thoracic Surgeons Terms and Conditions